J R Fozard. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acetaminophen/pharmacologyAdrenergic alpha-Antagonists/pharmacologyAnalgesics/pharmacologyAnimalsAspirin/pharmacologyCaffeine/pharmacologyClonidine/pharmacologyCyproheptadine/pharmacologyDihydroergotamine/pharmacologyErgotamine/pharmacologyHumansMethysergide/pharmacologyMigraine Disorders/drug therapyMonoamine Oxidase Inhibitors/pharmacologyMuscle, Smooth/drug effectsPizotyline/pharmacologySerotonin AntagonistsSympathetic Nervous System/drug effectsSynaptic Transmission/drug effectsTryptamines/antagonists & inhibitorsVagus Nerve/drug effectsVasoconstrictor Agents/pharmacologyVasodilator Agents/pharmacology
Substances: See more » Adrenergic alpha-AntagonistsAnalgesicsMonoamine Oxidase InhibitorsSerotonin AntagonistsTryptaminesVasoconstrictor AgentsVasodilator AgentsPizotylineCyproheptadineAcetaminophenCaffeineDihydroergotamineClonidineErgotamineAspirinMethysergide
Year: 1975 PMID: 239131 DOI: 10.1111/j.2042-7158.1975.tb09448.x
Source DB: PubMed Journal: J Pharm Pharmacol ISSN: 0022-3573 Impact factor: 3.765